Deborah Kilpatrick

Deborah Kilpatrick, PhD is the former CEO of Evidation Health in CA and a board director in public, private, and non-profit organizations in the health care landscape. Prior to her role at Evidation, a technology company that pioneered the use of person-generated health data in real world evidence, Deb’s medtech career focused on medical devices and molecular diagnostics in roles spanning R&D and commercialization. Early in her career, Deb was at Guidant Corporation in multiple leadership roles that included Research Fellow, Director of R&D, and Director of New Ventures in its Vascular Intervention Division prior to its acquisition by Boston Scientific (NYSE: BSX). Currently, she advises multiple startups while serving as a board director at Evidation, Sleep Number (NASDAQ: SNBR), women’s health company NextGen Jane, and Sutter Health—one of the nation’s largest and most innovative healthcare delivery systems providing care to millions in California. She is a Fellow of the American Institute of Medical and Biological Engineering and has been named to both the Digital Health Hall of Fame at UCSF and College of Engineering Hall of Fame at Georgia Tech. She has appeared in the San Francisco Business Times’ 100 Most Influential Women in Business, the Silicon Valley Business Journal’s 100 Women of Influence, FierceMedicalDevice’s Top Women in Medtech, and Forbes 50 Over 50 Entrepreneurs. She holds a B.S., M.S., and Ph.D. degrees in engineering from Georgia Tech.